Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Lomustine + MTX110 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Lomustine | Belustine | CCNU | ||
MTX110 | MTX-110|MTX 110 | MTX110 is a nanoparticle formulation of Panobinostat which can be delivered into the brain via convection-enhanced delivery (PMID: 29856296, PMID: 32357333). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05324501 | Phase I | MTX110 Lomustine + MTX110 | A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma (MAGIC-G1) | Active, not recruiting | USA | 0 |